Toth Financial Advisory’s Fulgent Genetics FLGT Stock Holding History

Toth Financial Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$6.51K	–	768
2024 Q1	$6.51K	Hold	300	–	–	﹤0.01%	498
2023 Q4	$8.67K	Hold	300	–	–	﹤0.01%	469
2023 Q3	$8.02K	Hold	300	–	–	﹤0.01%	464
2023 Q2	$11.1K	Hold	300	–	–	﹤0.01%	454
2023 Q1	$9.37K	Hold	300	–	–	﹤0.01%	466
2022 Q4	$8.93K	Hold	300	–	–	﹤0.01%	454
2022 Q3	$11K	Hold	300	–	–	﹤0.01%	437
2022 Q2	$16K	Hold	300	–	–	﹤0.01%	387
2022 Q1	$19K	Hold	300	–	–	﹤0.01%	393
2021 Q4	$30K	Sell	300 -600	-67%	-$52.7K	﹤0.01%	345
2021 Q3	$81K	Hold	900	–	–	0.01%	260
2021 Q2	$83K	Hold	900	–	–	0.01%	242
2021 Q1	$87K	Buy	900 +100	+13%	+$10.3K	0.01%	242
2020 Q4	$42K	Buy	800 +100	+14%	+$4.18K	0.01%	270
2020 Q3	$28K	Buy	700 +200	+40%	+$6.26K	0.01%	278
2020 Q2	$8K	Buy	+500	New	+$7.66K	﹤0.01%	373
2020 Q1	–	Sell	-150	Closed	-$2K	–	478
2019 Q4	$2K	Hold	150	–	–	﹤0.01%	421
2019 Q3	$2K	Buy	+150	New	+$1.42K	﹤0.01%	405

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Toth Financial Advisory's FLGT Position: Q2 2024 in Review

Toth Financial Advisory sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 300 shares — an estimated $6.51K sold.

Toth Financial Advisory first reported a position in FLGT in Q3 2019 and held it in 18 quarters. The position peaked at $87K in Q1 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

Toth Financial Advisory reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
Toth Financial Advisory sold 300 Fulgent Genetics shares in Q2 2024, an estimated $6.51K.
Toth Financial Advisory first reported a position in Fulgent Genetics in Q3 2019 and held it in 18 quarters.
Toth Financial Advisory's Fulgent Genetics position peaked at $87K in Q1 2021.
173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Toth Financial Advisory's 13F filing for Q2 2024, filed 16 Jul 2024.